The ground seems to be ready for a defense for humans against the coronavirus pandemic. Moderna Inc.’s vaccine candidate protected 16 monkeys in a trial. Its result in 30,000 humans is awaited, reported livemint.
Two injections of the vaccine protected against heavy exposure to the virus at two different levels of dosage, Moderna said in findings published on Tuesday in the New England Journal of Medicine, reported livemint.
The results on primates
The results, if they hold up in humans, suggest that the vaccine may be able to protect against Covid-19 in both the upper and lower airways, reported livemint quoting the study.
Phase 3 trial to determine the safety and efficacy of the vaccine will begin producing data in November or December. The U.S. government is providing $955 million to help fund the vaccine’s development.
Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, which is $11 more than another vaccine from Pfizer Inc and BioNTech, livemint quoted Financial Times as reporting on Tuesday, citing unnamed sources.
Bhubaneswar: Odisha cycling star Swasti Singh won three more silver medals on the second and…
New Delhi/Bhubaneswar: Senior IAS officer of Odisha cadre Tuhin Kanta Pandey was on Saturday appointed…
Bhubaneswar: Kabir Hans won the singles title in the MOSF-AITA-OTA Gurukul Mens 1 Lakh Tennis…
New Delhi: He had created the world’s smallest vacuum cleaner in 2020. Having lost the…
Bhubaneswar: Celebrated singer Kalaimamani Dr OS Arun and his orchestra captivated the audience with Carnatic…
Bhubaneswar: Ace Odisha shooter Shriyanka Sadangi boosted her National rankings by securing first position in…
Bhubaneswar: Thundershower accompanied by lightning is likely to occur in some parts of five districts…
Mumbai: In politics, there is no love lost even between family members. Furious at the…